Antipsychotic maintenance treatment versus dose reduction: how the story continues

Iris E.C. Sommer; Mark Horowitz; Kelly Allott; Helene Speyer; Marieke J.H. Begemann

doi:10.1016/S2215-0366(22)00230-9

Antipsychotic maintenance treatment versus dose reduction: how the story continues

Iris E.C. Sommer, Mark Horowitz, Kelly Allott, Helene Speyer, Marieke J.H. Begemann^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

6 Citations (Scopus)

185 Downloads (Pure)

Original language	English
Pages (from-to)	602-603
Number of pages	2
Journal	The Lancet Psychiatry
Volume	9
Issue number	8
DOIs	https://doi.org/10.1016/S2215-0366(22)00230-9
Publication status	Published - Aug-2022

Access to Document

10.1016/S2215-0366(22)00230-9

Antipsychotic maintenance treatment versus dose reductionFinal publisher's version, 67.6 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{aeeede9f1d4a4d749b04b57b321b7f6b,

title = "Antipsychotic maintenance treatment versus dose reduction: how the story continues",

author = "Sommer, {Iris E.C.} and Mark Horowitz and Kelly Allott and Helene Speyer and Begemann, {Marieke J.H.}",

note = "Funding Information: KA declares a Career Development Fellowship from the National Health and Medical Research Council of Australia which supports her salary to conduct independent research. All other authors have no competing interests.",

year = "2022",

month = aug,

doi = "10.1016/S2215-0366(22)00230-9",

language = "English",

volume = "9",

pages = "602--603",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "ELSEVIER SCI LTD",

number = "8",

}

TY - JOUR

T1 - Antipsychotic maintenance treatment versus dose reduction

T2 - how the story continues

AU - Sommer, Iris E.C.

AU - Horowitz, Mark

AU - Allott, Kelly

AU - Speyer, Helene

AU - Begemann, Marieke J.H.

N1 - Funding Information: KA declares a Career Development Fellowship from the National Health and Medical Research Council of Australia which supports her salary to conduct independent research. All other authors have no competing interests.

PY - 2022/8

Y1 - 2022/8

U2 - 10.1016/S2215-0366(22)00230-9

DO - 10.1016/S2215-0366(22)00230-9

M3 - Comment/Letter to the editor

C2 - 35753324

AN - SCOPUS:85134350785

SN - 2215-0366

VL - 9

SP - 602

EP - 603

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 8

ER -